Next Article in Journal
Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells
Previous Article in Journal
The significance of reduced glutathione and glutathione S-transferase during chemoradiotherapy of locally advanced cervical cancer
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle

Postmastectomy internal mammary nodal irradiation: A long-term outcome

1
Radiotherapy and Drug Therapy Centre, National Cancer Institute, Vilnius, Lithuania
2
Scientific Research Centre, National Cancer Institute, Vilnius, Lithuania
3
Cancer Control and Prevention Center, National Cancer Institute, Vilnius, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2014, 50(4), 230-236; https://doi.org/10.1016/j.medici.2014.09.010
Received: 30 April 2014 / Accepted: 15 September 2014 / Published: 7 October 2014
Background and objective: The internal mammary lymph nodes (IMN) have been recognized as a potential site of regional breast cancer spread. The aim of this study was to evaluate the impact of internal mammary node radiotherapy (RT) to on clinical outcomes in breast cancer patients treated with mastectomy and postoperative radiation therapy.
Materials and methods: This cohort study included 588 patients with breast cancers located in the central and medial quadrants. IMN RT was applied to 320 patients and 268 patients did not receive it IMN RT. Inside the IMN RT group, 165 patients received external beam IMN irradiation (IMN-EB). Mastectomy combined with using Californium-252 neutron source implantation was applied to 155 patients (IMN-BT). Cox proportional hazards modeling was used to determine the influence of IMN RT on clinical outcome. Age, tumor size, lymph nodal status, adjuvant radiotherapy, chemotherapy and hormonal therapy were assessed.
Results: IMN-EB resulted in a significant improvement of distant metastasis-free survival, breast cancer-specific survival and overall survival (P = 0.033, P = 0.037 and P = 0.011, respectively). The IMN-EB radiotherapy has a significant impact on event-free survival (HR, 0.67; 95% CI, 0.46–0.91; P = 0.043) and breast cancer-specific survival (HR, 0.64; 95% CI, 45–0.91; P = 0.013) in patients with moderate-risk (stage T1–2 N1). There was no association between IMN RT and clinical outcomes of patients with high-risk disease (stage T3–4 N2–3) in any of the study end points.
Conclusions: The effects of IMN-EB radiotherapy on event-free survival and breast cancer- specific survival were benefit for women with moderate-risk breast cancer.
Keywords: Breast cancer; Internal mammary lymph nodes; Radiotherapy Breast cancer; Internal mammary lymph nodes; Radiotherapy
MDPI and ACS Style

Aleknavičius, E.; Atkočius, V.; Kuzmickienė, I.; Steponavičienė, R. Postmastectomy internal mammary nodal irradiation: A long-term outcome. Medicina 2014, 50, 230-236.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop